Differential activation of subtype purinergic receptors modulates Ca(2+) mobilization and COX-2 in human microglia

Glia. 2003 Aug;43(2):95-103. doi: 10.1002/glia.10239.

Abstract

We have studied modulation of purinergic receptors (P(2Y) and P(2X) subtypes) on changes in intracellular Ca(2+) [Ca(2+)](i) and expression and production of COX-2 in human microglia. Measurements using Ca(2+)-sensitive spectrofluorometry showed adenosine triphosphate (ATP) to cause rapid transient increases in [Ca(2+)](i). Application of ATP plus the P(2X) antagonist, pyridoxal-phosphate-6-azophenyl-2',4'-disulfonic acid (PPADS), or treatment with adenosine diphosphate-beta-S (ADP-beta-S), a selective P(2Y) agonist, led to a considerable prolongation in [Ca(2+)](i) responses compared with ATP. The prolonged time courses were consistent with sustained activation of store-operated channels (SOC) since SKF96365, an inhibitor of SOC, blocked this component of the response. RT-PCR data showed that microglia expressed no COX-2 either constitutively or following treatment of cells with ATP (100 microM for 8 h). However, treatment using ATP plus PPADS or with ADP-beta-S led to marked expression of COX-2. The enhanced COX-2 with ATP plus PPADS treatment was absent in the presence of SKF96365 or using Ca(2+)-free solution. Immunocytochemistry, using a specific anti-COX-2 antibody, also revealed a pattern of purinergic modulation whereby lack of P(2X) activation enhanced the production of COX-2 protein. These results suggest that modulation of subtypes of purinergic receptors regulates COX-2 in human microglia with a link involving SOC-mediated influx of Ca(2+).

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenosine Diphosphate / analogs & derivatives*
  • Adenosine Diphosphate / pharmacology
  • Adenosine Triphosphate / pharmacology
  • Brain / cytology
  • Brain / embryology
  • Calcium / metabolism*
  • Cell Count / methods
  • Cell Size / drug effects
  • Cell Survival
  • Cells, Cultured
  • Cyclooxygenase 2
  • Drug Interactions
  • Embryo, Mammalian
  • Fluorescent Dyes / metabolism
  • Gene Expression / drug effects
  • Humans
  • Immunohistochemistry / methods
  • Indoles / metabolism
  • Isoenzymes / genetics
  • Isoenzymes / metabolism*
  • Membrane Proteins
  • Microglia / drug effects
  • Microglia / enzymology
  • Microglia / metabolism*
  • Platelet Aggregation Inhibitors / pharmacology
  • Prostaglandin-Endoperoxide Synthases / genetics
  • Prostaglandin-Endoperoxide Synthases / metabolism*
  • Purinergic Agonists
  • Purinergic Antagonists
  • RNA, Messenger / biosynthesis
  • Receptors, Purinergic / classification
  • Receptors, Purinergic / metabolism*
  • Reverse Transcriptase Polymerase Chain Reaction / methods
  • Spectrometry, Fluorescence / instrumentation
  • Thionucleotides / pharmacology

Substances

  • Fluorescent Dyes
  • Indoles
  • Isoenzymes
  • Membrane Proteins
  • Platelet Aggregation Inhibitors
  • Purinergic Agonists
  • Purinergic Antagonists
  • RNA, Messenger
  • Receptors, Purinergic
  • Thionucleotides
  • adenosine 5'-O-(2-thiodiphosphate)
  • DAPI
  • Adenosine Diphosphate
  • Adenosine Triphosphate
  • Cyclooxygenase 2
  • PTGS2 protein, human
  • Prostaglandin-Endoperoxide Synthases
  • Calcium